Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 421-300-1 | CAS number: 138564-59-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1996-03-06 to 1996-03-19
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- The study was conducted to the standards of the time: no preincubation study was conducted and the strains selected do not conform to current best practice.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial forward mutation assay
Test material
- Reference substance name:
- -
- EC Number:
- 421-300-1
- EC Name:
- -
- Cas Number:
- 138564-59-7
- Molecular formula:
- C12H9N3O2S
- IUPAC Name:
- 5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile
- Test material form:
- solid: particulate/powder
- Details on test material:
- 97.7%
Item code QA405K
Lilly lot no: 356MO1
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: sponsor and 356M01
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: In the dark at ambient temperature
- Solubility and stability of the test substance in the solvent/vehicle: Soluble
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: DMSO was used to dissolve and dilute
FORM AS APPLIED IN THE TEST (if different from that of starting material)
33, 100, 333, 1000, 3333, and 10000 ug/plate for the toxicity test.
For the two mutation tests, the concentrations were 3, 10, 33, 100, 333, and 100 ug/plate for the first test, and 2.5, 7.5, 25, 75, 250 and 750 ug/plate for the second test.
Method
- Target gene:
- his G 46 in TA 1535 and TA 100
his C 3076 in TA 1537
his D 3052 in TA 1538 and TA 98
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- Preparation of supernatant fluid from rat liver using S9 mix
- Test concentrations with justification for top dose:
- 33, 100, 333, 1000, 3333, and 10000 ug/plate for the toxicity test. The top dose was the maximum solubility of the test susbtance in the vehicle.
For the two mutation tests, the concentrations were 3, 10, 33, 100, 333, and 100 ug/plate for the first test, and 2.5, 7.5, 25, 75, 250 and 750 ug/plate for the second test. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- other: 2-aminoanthracene (2-AAN), sodium azide (NaN3)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation);
DURATION
- Preincubation period: 16 h
- Exposure duration: 2 days
- Expression time (cells in growth medium): 2 days
- Selection time (if incubation with a selection agent): 2 days
SELECTION AGENT (mutation assays):
An Aroclor 1254 induced rat liver preparation and co-factors (S9 mix) required for mixed-function oxidase activity
NUMBER OF REPLICATIONS:
3 for each control and test concentration with and without S9 mix
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED:
colonies were counted using a Biotran III automated counter (New Brunswick Incorporated, NJ, USA) at maximum sensitivity ie colonies of 0.1 mm or more in diameter counted.
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Rationale for test conditions:
- The particular damage induced to DNA by a mutagen may cause reversions to occur which are observable in certain strains of Salmonella typhimurium, but not in others. It is necessary, therefore, to use a variety of bacterial strains in order to test for a broad range of chemical mutagens. At the present time, available data suggest that the use of the 5 strains used in this project permits the detection of a wide spectrum of mutagens.
It is well recognised, however, that many chemicals which may be reactive in a mammalian cell, following metabolic activation, are quite inactive in bacterial cells.
Extracts of mammalian cells are combined, therefore, with the bacterial indicator cells in a tissue mediated assay to increase the relevance of the test in assessing the mutagenicity of chemicals to man. - Evaluation criteria:
- A test was considered acceptable if for each strain:
i) the bacteria demonstrated their typical responses to crystal violet,
ampicillin and u. v. light.
ii) on at least 2 of the vehicle control plates were within the following ranges: TA 1535, 4-30; TA 1537, 1-20; TA 98, 10-60; TA 100, 60-200 and
TA 1538, 5-35.
iii) on at least 2 of the positive control plates there were x 2 the mean vehicle control mutant numbers per plate, or in the case of TA 100, x 1.5 the mean vehicle control mutant numbers per plate. If the mean colony count on the vehicle control plates was less than 10 then a value of 10 was assumed for assessment purposes. In such cases a minimum count of 20 was required on at least 2 of the positive control plates.
iv) no toxicity or contamination was observed in at least 4 dose levels.
v) in cases where a mutagenic response was observed, that no more than one dose level was discarded before the dose which gave the highest significant mean colony number.
Where these criteria were met, a significant mutagenic response was recorded if there was:
i) for S. typhimurium strains TA 1535, TA 1537, TA 1538 and TA 98, at least a doubling of the mean concurrent vehicle control values at some concentration of the test substances and, for S. typhimurium strain TA 100, a 1.5-fold increase over the control value. If the mean colony count on the vehicle control plates was less than 10 then a value of 10 was assumed for assessment purposes. In such cases a minimum count of 20 was required before a significant mutagenic response was identified.
ii) a dose related response, although at high dose levels this relationship could be inverted because of, for example, (1) toxicity to the bacteria generally, (2) specific toxicity to the mutants and (3) inhibition of foreign compound metabolising enzymes where mutagens require metabolic activation by the liver.
iii) a reproducible effect in independent tests.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- All tests were acceptable according to the study criteria except the second mutation assay with Salmonella typhimurium TA 1537, the culture used was contaminated; This was repeated.
There was no toxicity to the bacteria. Precipitation of the test material occurred at 1000 µg per plate and above in the presence and absence of S9 mix.
All strains of S. typhimurium were sensitive to crystal violet, whereas only the plasmid-containing strains, TA 98 and TA 100, were resistant to ampicillin. The strains were also tested for sensitivity to u. v. light emitted over a period of 10 s from a CAMAG u.v. lamp set at 254 nm. Increased sensitivity to u.v. light was demonstrated. These results are consistent with the known properties of these bacteria.
Any other information on results incl. tables
Table 1 : toxicity screen
Strain | Dose level µg/plate | Liver S9 | mean revertant colony counts | SD | individual revertant colony counts |
TA100 | solvent | - | 135 | - | 135 |
33 | - | 123 | - | 123 | |
100 | - | 105 | - | 105 | |
333 | - | 122 | - | 122 | |
1000 | - | 114 | - | 114 P | |
3333 | - | 129 | - | 129 P | |
10000 | - | 120 | - | 120 P | |
solvent | + | 114 | - | 114 | |
33 | + | 128 | - | 128 | |
100 | + | 120 | - | 120 | |
333 | + | 123 | - | 123 | |
1000 | + | 142 | - | 142 P | |
3333 | + | 134 | - | 134 P | |
10000 | + | 121 | - | 121 P |
Table2: 1st repeat Plate incorporation with metabolic activation
substance | dose level µg/plate | TA 1535 mean ± SD |
TA 1537 mean ± SD |
TA 1538 mean ± SD |
TA 98 mean ± SD |
TA 100 mean ± SD |
DMSO | 100µl | 12 ± 2 | 12 ± 5 | 14 ± 5 | 20 ± 4 | 104 ± 12 |
TCN intermediate | 3 | 7 ± 2 | 18 ± 5 | 25 ± 1 | 22 ± 5 | 113 ± 21 |
10 | 6 ± 3 | 14 ± 2 | 20 ± 3 | 35 ± 3 | 120 ± 14 | |
33 | 4 ± 2 | 10 ± 2 | 17 ± 7 | 31 ± 2 | 102 ± 10 | |
100 | 12 ± 2 | 10 ± 2 | 20 ± 4 | 31 ± 6 | 106 ± 9 | |
333 (P) | 13 ± 3 | 16 ± 2 | 23 ± 4 | 27 ± 6 | 102 ± 12 | |
1000 (P) | 9 ± 3 | 9 ± 4 | 16 ± 4 | 27 ± 8 | 125 ± 6 | |
Positive Controls | Compound | 2AAN | 2AAN | 2AAN | 2AAN | 2AAN |
Dose level | 2µg | 2µg | 0.5µg | 0.5µg | 0.5µg | |
mean ± SD | 120 ± 15 | 78± 4 | 204± 12 | 186± 18 | 350± 38 |
Table 3: 2nd repeat plate incorporation with metabolic activation
substance | dose level µg/plate | TA 1535 mean ± SD |
TA 1537 mean ± SD |
TA 1538 mean ± SD |
TA 98 mean ± SD |
TA 100 mean ± SD |
DMSO | 100µl | 13 ± 4 | 14 ± 4 | 12 ± 4 | 33 ± 3 | 147 ± 10 |
TCN intermediate | 2.5 | 13 ± 2 | 30 ± 9 | 14 ± 4 | 31 ± 9 | 125 ± 16 |
7.5 | 7 ± 3 | 22 ± 3 | 7 ± 3 | 30 ± 7 | 133 ± 8 | |
25 | 8 ± 4 | 17 ± 2 | 15 ± 3 | 36 ± 2 | 125 ± 18 | |
75 | 10 ± 8 | 14 ± 1 | 19 ± 3 | 36 ± 8 | 145 ± 6 | |
250 | 11 ±2 | 11 ± 4 | 17 ± 6 | 34 ± 5 | 132 ± 1 | |
750 (P) | 12 ± 4 | 12 ± 5 | 12 ± 7 | 30 ± 2 | 139 ± 16 | |
Positive Controls | Compound | 2AAN | 2AAN | 2AAN | 2AAN | 2AAN |
Dose level | 2µg | 2µg | 0.5µg | 0.5µg | 0.5µg | |
mean ± SD | 145 ± 15 | 115± 16 | 218± 26 | 197± 20 | 301± 23 |
Table 4: 1st repeat plate incorporation without metabolic activation
substance | dose level µg/plate | TA 1535 mean ± SD |
TA 1537 mean ± SD |
TA 1538 mean ± SD |
TA 98 mean ± SD |
TA 100 mean ± SD |
DMSO | 100µl | 8 ± 4 | 8 ± 4 | 14 ± 5 | 18 ± 4 | 98 ± 4 |
TCN intermediate | 3 | 7 ± 4 | 9 ±3 | 12 ± 2 | 18 ± 9 | 96 ± 18 |
10 | 7 ± 3 | 9 ±6 | 10 ±4 | 20 ± 7 | 102 ± 9 | |
33 | 8 ± 1 | 5 ± 3 | 12 ± 1 | 20 ± 1 | 102 ± 9 | |
100 | 9 ± 3 | 10 ± 1 | 9 ± 2 | 19 ± 2 | 94 ± 5 | |
333 (P) | 13 ±2 | 9 ± 4 | 12 ± 1 | 18 ± 2 | 131 ± 6 | |
1000 (P) | 11 ± 2 | 6 ± 4 | 11 ± 5 | 16 ± 3 | 118 ± 14 | |
Positive Controls | Compound | NaN3 | 9AA | 2NF | 2NF | NaN3 |
Dose level | 1µg | 80µg | 1µg | 1µg | 1µg | |
mean ± SD | 209 ± 26 | 816± 80 | 233± 38 | 222± 29 | 541± 60 |
Table 5 2nd repeat without metabolic activation
substance | dose level µg/plate | TA 1535 mean ± SD |
TA 1537 mean ± SD |
TA 1538 mean ± SD |
TA 98 mean ± SD |
TA 100 mean ± SD |
DMSO | 100µl | 12 ± 3 | 15 ± 2 | 7 ± 2 | 24 ± 2 | 126 ± 4 |
TCN intermediate | 2.5 | 10 ± 3 | 19 ± 3 | 9 ± 3 | 18 ± 3 | 132 ± 7 |
7.5 | 11 ± 7 | 19 ± 4 | 6 ± 3 | 24 ± 2 | 130 ± 13 | |
25 | 9 ± 1 | 19 ± 2 | 7 ± 4 | 21 ± 5 | 140 ± 15 | |
75 | 7 ± 5 | 13 ± 3 | 8 ± 3 | 14 ± 6 | 139 ± 3 | |
250 (P) | 8 ±2 | 14 ± 2 | 8 ± 3 | 27 ± 3 | 142 ± 9 | |
750 (P) | 6 ± 2 | 10 ± 2 | 6 ± 3 | 24 ± 4 | 131 ± 10 | |
Positive Controls | Compound | NaN3 | 9AA | 2NF | 2NF | NaN3 |
Dose level | 1µg | 80µg | 1µg | 1µg | 1µg | |
mean ± SD | 181 ± 17 | 837± 158 | 229± 9 | 198± 10 | 287± 6 |
Key (P) = precipitate; NaN3 = sodium azide, 9AA = 9 -aminoacridine, 2NF= 2 -nitrofluorene, 2AAN= 2 -aminoanthracene. SD = standard deviation
Applicant's summary and conclusion
- Conclusions:
- This study found that the test substance does not induce mutagenicity when tested according to OECD guidelines.
- Executive summary:
This study was carried out in accordance with OECD guideline 471. The test substance was tested for mutagenic activity in Salmonella typhimurium strains TA 1535, TA 1537, TA 1538, TA 98 and TA 100 at concentrations ranging from 2.5 to 1000ug per plate.
The tests were conducted on agar plates in the presence and absence of an Aroclor 1254 induced rat liver preparation and co-factors (S9 mix) required for mixed-function oxidase activity. Concurrent positive controls demonstrated the sensitivity of the assay and the metabolising activity of the S9 mix.
The results obtained in both experiments were similar. No mutagenic activity was observed in any of the 5 bacterial strains, in either activation conditions.
Precipitation of the test material was observed at doses of 250ug per plate and above. There was no toxicity to the bacteria. It was concluded that the test substance was not mutagenic to Salmonella typhimurium when tested in dimethylsulphoxide up to the limit of its solubility.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.